chr14-20457272-G-A

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_001641.4(APEX1):​c.721G>A​(p.Gly241Arg) variant causes a missense change. The variant allele was found at a frequency of 0.00101 in 1,614,210 control chromosomes in the GnomAD database, including 20 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.0052 ( 11 hom., cov: 33)
Exomes 𝑓: 0.00057 ( 9 hom. )

Consequence

APEX1
NM_001641.4 missense

Scores

6
12

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: 3.93

Publications

22 publications found
Variant links:
Genes affected
APEX1 (HGNC:587): (apurinic/apyrimidinic endodeoxyribonuclease 1) The APEX gene encodes the major AP endonuclease in human cells. It encodes the APEX endonuclease, a DNA repair enzyme with apurinic/apyrimidinic (AP) activity. Such AP activity sites occur frequently in DNA molecules by spontaneous hydrolysis, by DNA damaging agents or by DNA glycosylases that remove specific abnormal bases. The AP sites are the most frequent pre-mutagenic lesions that can prevent normal DNA replication. Splice variants have been found for this gene; all encode the same protein. Disruptions in the biological functions related to APEX are associated with many various malignancies and neurodegenerative diseases.[provided by RefSeq, Dec 2019]
APEX1 Gene-Disease associations (from GenCC):
  • amyotrophic lateral sclerosis
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.008568823).
BP6
Variant 14-20457272-G-A is Benign according to our data. Variant chr14-20457272-G-A is described in ClinVar as Benign. ClinVar VariationId is 709908.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00519 (791/152320) while in subpopulation AFR AF = 0.0183 (761/41574). AF 95% confidence interval is 0.0172. There are 11 homozygotes in GnomAd4. There are 377 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High AC in GnomAd4 at 791 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
APEX1NM_001641.4 linkc.721G>A p.Gly241Arg missense_variant Exon 5 of 5 ENST00000216714.8 NP_001632.2 P27695Q5TZP7
APEX1NM_001244249.2 linkc.721G>A p.Gly241Arg missense_variant Exon 5 of 5 NP_001231178.1 P27695Q5TZP7
APEX1NM_080648.3 linkc.721G>A p.Gly241Arg missense_variant Exon 5 of 5 NP_542379.1 P27695Q5TZP7
APEX1NM_080649.3 linkc.721G>A p.Gly241Arg missense_variant Exon 5 of 5 NP_542380.1 P27695Q5TZP7

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
APEX1ENST00000216714.8 linkc.721G>A p.Gly241Arg missense_variant Exon 5 of 5 1 NM_001641.4 ENSP00000216714.3 P27695

Frequencies

GnomAD3 genomes
AF:
0.00520
AC:
792
AN:
152202
Hom.:
11
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0184
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00131
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000588
Gnomad OTH
AF:
0.00239
GnomAD2 exomes
AF:
0.00138
AC:
348
AN:
251496
AF XY:
0.00100
show subpopulations
Gnomad AFR exome
AF:
0.0187
Gnomad AMR exome
AF:
0.000896
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000791
Gnomad OTH exome
AF:
0.000651
GnomAD4 exome
AF:
0.000575
AC:
840
AN:
1461890
Hom.:
9
Cov.:
33
AF XY:
0.000498
AC XY:
362
AN XY:
727246
show subpopulations
African (AFR)
AF:
0.0199
AC:
666
AN:
33480
American (AMR)
AF:
0.000917
AC:
41
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26136
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39700
South Asian (SAS)
AF:
0.0000348
AC:
3
AN:
86254
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53420
Middle Eastern (MID)
AF:
0.00104
AC:
6
AN:
5768
European-Non Finnish (NFE)
AF:
0.0000378
AC:
42
AN:
1112012
Other (OTH)
AF:
0.00136
AC:
82
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.487
Heterozygous variant carriers
0
60
120
181
241
301
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
22
44
66
88
110
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00519
AC:
791
AN:
152320
Hom.:
11
Cov.:
33
AF XY:
0.00506
AC XY:
377
AN XY:
74478
show subpopulations
African (AFR)
AF:
0.0183
AC:
761
AN:
41574
American (AMR)
AF:
0.00131
AC:
20
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5192
South Asian (SAS)
AF:
0.000207
AC:
1
AN:
4830
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10618
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0000588
AC:
4
AN:
68016
Other (OTH)
AF:
0.00236
AC:
5
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
39
77
116
154
193
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00122
Hom.:
6
Bravo
AF:
0.00565
ESP6500AA
AF:
0.0134
AC:
59
ESP6500EA
AF:
0.000116
AC:
1
ExAC
AF:
0.00166
AC:
201
Asia WGS
AF:
0.00115
AC:
4
AN:
3478
EpiCase
AF:
0.000164
EpiControl
AF:
0.0000593

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Dec 31, 2019
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

APEX1-related disorder Benign:1
May 01, 2019
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.26
BayesDel_addAF
Benign
-0.32
T
BayesDel_noAF
Benign
-0.21
CADD
Uncertain
24
DANN
Uncertain
1.0
DEOGEN2
Benign
0.19
T;T;T;T;.
Eigen
Uncertain
0.49
Eigen_PC
Uncertain
0.56
FATHMM_MKL
Uncertain
0.84
D
LIST_S2
Uncertain
0.94
.;.;D;D;D
MetaRNN
Benign
0.0086
T;T;T;T;T
MetaSVM
Benign
-0.29
T
MutationAssessor
Benign
0.50
N;N;.;N;.
PhyloP100
3.9
PrimateAI
Uncertain
0.58
T
PROVEAN
Benign
-0.41
N;N;N;N;N
REVEL
Benign
0.20
Sift
Benign
0.030
D;D;D;D;T
Sift4G
Benign
0.16
T;T;T;T;T
Polyphen
1.0
D;D;.;D;.
Vest4
0.45
MutPred
0.51
Gain of solvent accessibility (P = 0.0456);Gain of solvent accessibility (P = 0.0456);Gain of solvent accessibility (P = 0.0456);Gain of solvent accessibility (P = 0.0456);.;
MVP
0.82
MPC
0.74
ClinPred
0.030
T
GERP RS
5.6
Varity_R
0.83
gMVP
0.85
Mutation Taster
=94/6
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs33956927; hg19: chr14-20925431; API